PHI1 Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for PHI1 from our risk checks.
Koninklijke Philips N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €18.78 |
52 Week High | €22.12 |
52 Week Low | €15.30 |
Beta | 0.78 |
1 Month Change | 0.81% |
3 Month Change | -11.18% |
1 Year Change | 19.86% |
3 Year Change | -59.93% |
5 Year Change | -43.58% |
Change since IPO | -43.07% |
Recent News & Updates
Recent updates
Shareholder Returns
PHI1 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 0.2% | 2.4% | 2.5% |
1Y | 19.9% | 7.2% | 7.0% |
Return vs Industry: PHI1 exceeded the German Medical Equipment industry which returned 7.2% over the past year.
Return vs Market: PHI1 exceeded the German Market which returned 7% over the past year.
Price Volatility
PHI1 volatility | |
---|---|
PHI1 Average Weekly Movement | 3.4% |
Medical Equipment Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHI1 has not had significant price volatility in the past 3 months.
Volatility Over Time: PHI1's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1891 | 69,656 | Roy Jakobs | https://www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
PHI1 fundamental statistics | |
---|---|
Market cap | €17.03b |
Earnings (TTM) | -€456.00m |
Revenue (TTM) | €18.17b |
0.9x
P/S Ratio-37.3x
P/E RatioIs PHI1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHI1 income statement (TTM) | |
---|---|
Revenue | €18.17b |
Cost of Revenue | €10.72b |
Gross Profit | €7.45b |
Other Expenses | €7.90b |
Earnings | -€456.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
Earnings per share (EPS) | -0.50 |
Gross Margin | 40.99% |
Net Profit Margin | -2.51% |
Debt/Equity Ratio | 54.8% |
How did PHI1 perform over the long term?
See historical performance and comparison